🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will look at the change in participants' body weight from the st...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-01-21
Trial ID
NCT03811574
Treatments Being Tested
This study investigates the Topical-Lingual (T-L) delivery of semaglutide, ...
Status
Recruiting
Location
Clinical Research Institute of Minnesota
Start Date
2026-06-17
Trial ID
NCT07728383
In this exploratory, single-arm, nonrandomized trial, the impact of the pre...
Status
Not Yet Recruiting
Location
Banner MD Anderson Cancer Center at Gateway
Start Date
2026-07
Trial ID
NCT07727473
Treatments Being Tested
The study is looking at possible new medicines for weight control in people...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-10-15
Trial ID
NCT03707990
Treatments Being Tested
The Joule MARS study is a single center, randomized, open label clinical tr...
Status
Recruiting
Location
McMaster University
Start Date
2025-06-18
Trial ID
NCT06852391
Treatments Being Tested
The purpose of this study is to investigate how safe, and how well tolerate...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2020-02-17
Trial ID
NCT04259801
Treatments Being Tested
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open...
Status
Recruiting
Location
London Health Sciences Centre
Start Date
2024-09-26
Trial ID
NCT06396416
Treatments Being Tested
This multicenter, randomized, double-blind, placebo- and open-label active ...
Status
Active Not Recruiting
Location
Arizona Liver Health - Tucson
Start Date
2025-08-19
Trial ID
NCT07112872
Treatments Being Tested
This trial is conducted in Europe. The aim of the trial is to investigate t...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01866748
Treatments Being Tested
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, primaril...
Status
Unknown
Location
Greenstone Biosciences
Start Date
2024-07-10
Trial ID
NCT06541509
Treatments Being Tested